Minivelle
Minivelle is Noven's small twice-a-week patch. ASHP's shortage bulletin says the Minivelle brand was discontinued in February, while Noven's unbranded version of the same patch is still sold. That version is on intermittent back order with weekly releases, which Noven puts down to higher demand.
Two other makers have patches the FDA rates against Minivelle: Mylan, whose version ASHP lists as available in every strength, and Amneal, whose Lyllana is also listed as available. Mylan's patch is larger than Minivelle at each strength.
- Made by
- Noven
- Changed
- Twice a week
- Strengths
- 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg, 0.1 mg
- FDA approval
- NDA 203752
- Medfinder in-stock rate
- 3% of 102 checks
Status, with the patches rated against it
| Patch | 0.025 mg | 0.0375 mg | 0.05 mg | 0.075 mg | 0.1 mg |
|---|---|---|---|---|---|
| MinivelleNoven · twice a week | Discontinued | Discontinued | Discontinued | Discontinued | Discontinued |
| Noven twice-weeklyNoven · twice a week | Limited | Limited | Limited | Limited | Limited |
| Mylan twice-weekly (MV)Mylan (Viatris) · twice a week | Available | Available | Available | Available | Available |
| LyllanaAmneal · twice a week | Available | Available | Available | Available | Available |
- Available
- Limited
- Short
- Discontinued
- No data
Statuses checked October 18, 2026 against each row's source. We re-check every week.
Each strength in detail
0.025 mg (discontinued) · 0.0375 mg (discontinued) · 0.05 mg (discontinued) · 0.075 mg (discontinued) · 0.1 mg (discontinued)
Any change of brand, strength or form is a decision for your prescriber, and your pharmacist can check what they can order.
Get one email when your strength is back
Pick the strength on your box. When ASHP, the makers or Drug Shortages Canada list it as back in normal supply, we write once with what changed.
Sources
- Minivelle label, DailyMed, Noven, July 31, 2026.
- Estradiol transdermal system (authorized generic of Minivelle) label, DailyMed, Noven, April 5, 2024.
- Estradiol transdermal system, twice weekly (ANDA 206685) label, DailyMed, Mylan, June 23, 2025.
- Lyllana label, DailyMed, Amneal, May 15, 2024.
- Drug Shortage Detail: Estradiol Transdermal System, ASHP, August 12, 2026.
- Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (data files), FDA, October 9, 2026.
- Estradiol shortage tracker, Medfinder, October 18, 2026.